TORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of ...

"Does she have any flaws at all?" My business partner asked aloud, after we had just finished interviewing a strong candidate ...

LONG BEACH, Calif. -- Outcomes in neovascular age-related macular degeneration (nAMD) failed to improve with the addition of ...

LONG BEACH, Calif. -- Concomitant treatment with drugs for geographic atrophy (GA) and neovascular macular degeneration (nAMD ...

The White House, along with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., is celebrating.

Ozzy Osbourne was best known for two things: his shape-shifting resilience as a pioneer of heavy metal music and, most ...

The American College of Obstetricians and Gynecologists (ACOG) will no longer accept federal funding, citing federal policy ...

Donanemab, approved by the FDA in 2024 to treat Alzheimer's disease, is a monoclonal antibody directed at N-terminally ...

For clinicians managing PTLDS, the CDC released a toolkit in 2024 and the American Medical Association launched a continuing ...

TORONTO -- Blood tests for Alzheimer's disease biomarkers can be used clinically -- and can replace expensive brain scans and ...

Yonker is a co-inventor on a patent for zonulin antagonists to treat MIS-C, as are two other co-authors. Co-authors also ...